v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net revenues $ 51 $ 78 $ 90 $ 124
Costs and operating expenses:        
Cost of goods sold 278 234 591 460
Research and development 3,132 2,485 6,774 5,233
Sales and marketing 181 361 345 719
General and administrative 2,029 2,068 3,908 3,889
Total costs and operating expenses 5,620 5,148 11,618 10,301
Operating loss (5,569) (5,070) (11,528) (10,177)
Other income (expense):        
Change in fair value of forward purchase agreement warrant liability 23 37 10 458
Loss on offering and change in fair value of private warrant liability (838) 1,167
Change in fair value of publicly traded warrant liability 236 (32) (154) 162
Interest expense (related party) (624) (1,119)
Other income (expense), net 166 (1) 172 (12)
Total other income (expense), net (413) (620) 1,195 (511)
Net loss (5,982) (5,690) (10,333) (10,688)
Cumulative preferred dividends (1,290) (1,252) (2,640) (2,490)
Net loss attributable to common stockholders, basic (7,272) (6,942) (12,973) (13,178)
Net loss attributable to common stockholders, diluted $ (7,272) $ (6,942) $ (12,973) $ (13,178)
Net loss per share attributable to common stockholders, basic $ (0.07) $ (0.32) $ (0.15) $ (0.62)
Net loss per share attributable to common stockholders, diluted $ (0.07) $ (0.32) $ (0.15) $ (0.62)
Weighted-average Class A Common Stock and pre-funded warrants outstanding, basic (in Shares) 104,039,109 21,383,852 86,584,007 21,355,388
Weighted-average Class A Common Stock and pre-funded warrants outstanding, diluted (in Shares) 104,039,109 21,383,852 86,584,007 21,355,388
Other comprehensive (loss) income:        
Foreign currency translation adjustment $ (1) $ (2) $ (2) $ 4
Other comprehensive (loss) income (1) (2) (2) 4
Comprehensive loss $ (5,983) $ (5,692) $ (10,335) $ (10,684)